← Open Payments lookup

MARTHA AKINBILE: Open Payments

NPI 1164943403 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,585 in 58 payments from 12 companies in 2025. Trend: 2023 $850 · 2024 $586 · 2025 $1,585

Food & beverage: $1,569Education: $16
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$494
ABBVIE INC.16$334
Alkermes, Inc.6$179
Vanda Pharmaceuticals Inc.7$136
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$136
Takeda Pharmaceuticals U.S.A., Inc.4$87
Almatica Pharma LLC2$57
Neurocrine BioSciences, Inc.2$52
Janssen Pharmaceuticals, Inc1$30
E.R. Squibb & Sons, L.L.C.1$30

Products named: VRAYLAR, REXULTI, ARISTADA, FANAPT, CAPLYTA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, TRINTELLIX.

Industry payments across TX — which companies pay providers there.